Stock Quote

Merck KGaA (MRCG.DE) (Xetra)
As of  11:35am EST
65.46EUR
Price Change
+0.28
Percent Change
+0.43%
 
€65.46
11:35am EST
+0.43%
€65.18
€64.30
370,382
€65.89
€64.28
€75.04
€55.16
0.46
532,329

Research Another Stock: Symbol Look-up
Blame game slows growth of personalised medicine
Thursday, 26 Nov 2009 08:34am EST 
Blame game slows growth of personalized medicine
Thursday, 26 Nov 2009 07:50am EST 
European shares gain; drugmakers, miners support
Wednesday, 25 Nov 2009 10:46am EST 
European shares edge higher; miners up, banks slip
Tuesday, 24 Nov 2009 08:09am EST 
NICE again rejects Roche bowel cancer drug
Monday, 23 Nov 2009 08:59pm EST 
3 Stocks Springing Back
4:47am EST(The Motley Fool) 
3 China Profit Plays
4:29am EST(The Motley Fool) 
Merck Triumphant in Defense of Osteoporosis Drug.. for Now
Thursday, 26 Nov 2009 03:27am EST(Seeking Alpha) 
A Big Upgrade for Amylin Pharmaceuticals
Wednesday, 25 Nov 2009 10:16am EST(The Motley Fool) 
Still Enjoying Those Acquisitions, Pfizer?
Wednesday, 25 Nov 2009 09:52am EST(The Motley Fool) 
 
Name Current Position Compensation
Krebs, Rolf Chairman of the Supervisory Board --
Kley, Karl-Ludwig Chairman of the Executive Board --
Wilhelm, Heiner Vice Chairman of the Supervisory Board, Employee Representative --

Profile

Merck KGaA is a Germany-based company, operating in the pharmaceutical and chemical business sectors. The Pharmaceuticals business includes the development and production of prescription drugs and over-the-counter products, and operates through the Merck Serono division, which focuses on the... Full Description

Company Address

Merck KGaA
Frankfurter Strasse 250
Darmstadt     64293
P: +496151.720
F: +496151.722000

Analyst Research

  MRCG.DE Industry
P/E(TTM) 453.74 3.66
P/S(TTM) 1.86 0.55
ROI(TTM) 0.31 1.88
ROE(TTM) 0.33 2.54
Consensus Recommendation Outperform
EPS Est. (Current Period) --
EPS Est. (Current Year) --
Total Revenue $1,943.90M
Net Income $148.10M
EPS $0.66